Thursday February 22, 2018 23:53

Heathcare Press Release : 12 Dec 2017

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids Heathcare—12 Dec 17

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for Heathcare—12 Dec 17

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2